Does preexisting heart failure affect the use of anthracyclines and chemotherapy in older patients with newly diagnosed DLBCL?
Preexisting heart failure in older patients with DLBCL is associated with reduced utilization of anthracyclines and chemotherapy.
In this study, preexisting HF in patients with newly diagnosed DLBCL was common and was associated with lower use of anthracyclines and lower use of any chemotherapy. Trials are needed for this high-risk population.
Upshaw et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: